RHONDA MUNOZ: Open Payments
NPI 1376017301 · HARLINGEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$823 in 33 payments from 9 companies in 2025. Trend: 2023 $664 · 2024 $738 · 2025 $823
Food & beverage: $823
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $340 |
| Lilly USA, LLC | 15 | $152 |
| REVANCE THERAPEUTICS, INC. | 1 | $126 |
| Novo Nordisk Inc | 3 | $51 |
| ABBVIE INC. | 3 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| Verona Pharma, Inc. | 1 | $28 |
| Exact Sciences Corporation | 1 | $27 |
| Mannkind Corporation | 1 | $22 |
Products named: AIRSUPRA, BREZTRI, MOUNJARO, DAXXIFY, FARXIGA, Ozempic, VRAYLAR, XIFAXAN.
Industry payments across TX — which companies pay providers there.
